Cargando…

Capitalizing on ATRX loss in glioma via PARP inhibition: Comment on “Loss of ATRX confers DNA repair defects and PARP inhibitor sensitivity” by Garbarino et al.

Detalles Bibliográficos
Autores principales:	Zalenski, Abigail A, Venere, Monica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271166/ https://www.ncbi.nlm.nih.gov/pubmed/34242965 http://dx.doi.org/10.1016/j.tranon.2021.101173

Ejemplares similares

Loss of ATRX confers DNA repair defects and PARP inhibitor sensitivity
por: Garbarino, Jennifer, et al.
Publicado: (2021)

Loss of ATRX Does Not Confer Susceptibility to Osteoarthritis
por: Solomon, Lauren A., et al.
Publicado: (2013)

Loss of ATRX leads to chromosome cohesion and congression defects
por: Ritchie, Kieran, et al.
Publicado: (2008)

HGG-50. Specific sensitivity of pediatric high-grade glioma with ATRX inactivation to PARP inhibitor combinations
por: Laemmerer, Anna, et al.
Publicado: (2022)

ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma
por: Han, Bo, et al.
Publicado: (2020)

The Role of ATRX in Glioma Biology
por: Nandakumar, Pravanya, et al.
Publicado: (2017)

ATRX Loss in the Development and Prognosis of Conjunctival Melanoma
por: van Ipenburg, Jolique A., et al.
Publicado: (2023)

Significance of TERT and ATRX mutations in glioma
por: Liu, Jiayu, et al.
Publicado: (2019)

NFB-01. FUNCTIONAL CHARACTERIZATION OF ATRX LOSS IN NF1-ASSOCIATED GLIOMA AND MPNST
por: Yuan, Ming, et al.
Publicado: (2020)

ATRX status in patients with gliomas: Radiomics analysis
por: Meng, Linlin, et al.
Publicado: (2022)

Characterisation of an Atrx Conditional Knockout Mouse Model: Atrx Loss Causes Endocrine Dysfunction Rather Than Pancreatic Neuroendocrine Tumour
por: Gaspar, Tiago Bordeira, et al.
Publicado: (2022)

Loss of ATRX in Chondrocytes Has Minimal Effects on Skeletal Development
por: Solomon, Lauren A., et al.
Publicado: (2009)

Cellular and molecular mechanisms of neuronal loss in Atrx-knockout mice
por: Lagali, Pamela S, et al.
Publicado: (2013)

Ribosomal DNA copy loss and repeat instability in ATRX-mutated cancers
por: Udugama, Maheshi, et al.
Publicado: (2018)

IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas
por: Leeper, Heather E., et al.
Publicado: (2015)

Disruption of ATRX-RNA interactions uncovers roles in ATRX localization and PRC2 function
por: Ren, Wenqing, et al.
Publicado: (2020)

The Multiple Facets of ATRX Protein
por: Valenzuela, Martina, et al.
Publicado: (2021)

Loss of Atrx Affects Trophoblast Development and the Pattern of X-Inactivation in Extraembryonic Tissues
por: Garrick, David, et al.
Publicado: (2006)

ATRX Dysfunction Induces Replication Defects in Primary Mouse Cells
por: Clynes, David, et al.
Publicado: (2014)

Phosphorylated Hsp27 is mutually exclusive with ATRX loss and the IDH1(R132H) mutation and may predict better prognosis among glioblastomas without the IDH1 mutation and ATRX loss
por: Cai, Hong-Qing, et al.
Publicado: (2018)

ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma
por: Babikir, Husam, et al.
Publicado: (2021)

The Loss of ATRX Increases Susceptibility to Pancreatic Injury and Oncogenic KRAS in Female But Not Male Mice
por: Young, Claire C., et al.
Publicado: (2018)

Loss of atrx cooperates with p53-deficiency to promote the development of sarcomas and other malignancies
por: Oppel, Felix, et al.
Publicado: (2019)

ATRX represses alternative lengthening of telomeres
por: Napier, Christine E., et al.
Publicado: (2015)

Structural basis for DAXX interaction with ATRX
por: Wang, Xiaoman, et al.
Publicado: (2017)

Inactivation of hepatic ATRX in Atrx Foxg1cre mice prevents reversal of aging-like phenotypes by thyroxine
por: Rowland, Megan E., et al.
Publicado: (2018)

Loss of Maternal ATRX Results in Centromere Instability and Aneuploidy in the Mammalian Oocyte and Pre-Implantation Embryo
por: Baumann, Claudia, et al.
Publicado: (2010)

Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma
por: Akter, Jesmin, et al.
Publicado: (2021)

Targeting Telomerase and ATRX/DAXX Inducing Tumor Senescence and Apoptosis in the Malignant Glioma
por: Fan, Hueng-Chuen, et al.
Publicado: (2019)

Structural and biochemical characterization of DAXX-ATRX interaction
por: Li, Zhuang, et al.
Publicado: (2017)

MYCN amplification and ATRX mutations are incompatible in neuroblastoma
por: Zeineldin, Maged, et al.
Publicado: (2020)

Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway
por: Lovejoy, Courtney A., et al.
Publicado: (2012)

Loss of Wild-Type ATRX Expression in Somatic Cell Hybrids Segregates with Activation of Alternative Lengthening of Telomeres
por: Bower, Kylie, et al.
Publicado: (2012)

Loss of Atrx Sensitizes Cells to DNA Damaging Agents through p53-Mediated Death Pathways
por: Conte, Damiano, et al.
Publicado: (2012)

Loss of ATRX, associated with DNA methylation pattern of chromosome end, impacted biological behaviors of astrocytic tumors
por: Cai, Jinquan, et al.
Publicado: (2015)

Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation?
por: Marinoni, Ilaria
Publicado: (2022)

Dataset of differentially expressed genes in mouse P12 testes in response to the loss of ATRX in Sertoli cells
por: Bagheri-Fam, Stefan, et al.
Publicado: (2022)

Loss of ATRX promotes aggressive features of osteosarcoma with increased NF-κB signaling and integrin binding
por: Bartholf DeWitt, Suzanne, et al.
Publicado: (2022)

ATRX immunostaining predicts IDH and H3F3A status in gliomas
por: Ebrahimi, Azadeh, et al.
Publicado: (2016)

The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype
por: Amorim, João P., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9ncbrnq31b7dpphd2b7n7hfsij